The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Metrangolo, V.; Ploug, M.; Engelholm, L.H

Journal title: Cancers

Journal number: 13

Journal publisher: Multidisciplinary Digital Publishing Institute (MDPI)

Published year: 2021

DOI identifier: 10.3390/cancers13215376

ISSN: 2072-6694